{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T10:59:18Z","timestamp":1769857158388,"version":"3.49.0"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2004,10,14]],"date-time":"2004-10-14T00:00:00Z","timestamp":1097712000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                        <jats:title>Background<\/jats:title>\n                        <jats:p>For \u2248 24 years the AIDS pandemic has claimed \u2248 30 million lives, causing \u2248 14,000 new HIV-1 infections daily worldwide in 2003. About 80% of infections occur by heterosexual transmission. In the absence of vaccines, topical microbicides, expected to block virus transmission, offer hope for controlling the pandemic. Antiretroviral chemotherapeutics have decreased AIDS mortality in industrialized countries, but only minimally in developing countries. To prevent an analogous dichotomy, microbicides should be: acceptable; accessible; affordable; and accelerative in transition from development to marketing. Already marketed pharmaceutical excipients or foods, with established safety records and adequate anti-HIV-1 activity, may provide this option.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Methods<\/jats:title>\n                        <jats:p>Fruit juices were screened for inhibitory activity against HIV-1 IIIB using CD4 and CXCR4 as cell receptors. The best juice was tested for inhibition of: (1) infection by HIV-1 BaL, utilizing CCR5 as the cellular coreceptor; and (2) binding of gp120 IIIB and gp120 BaL, respectively, to CXCR4 and CCR5. To remove most colored juice components, the adsorption of the effective ingredient(s) to dispersible excipients and other foods was investigated. A selected complex was assayed for inhibition of infection by primary HIV-1 isolates.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Results<\/jats:title>\n                        <jats:p>HIV-1 entry inhibitors from pomegranate juice adsorb onto corn starch. The resulting complex blocks virus binding to CD4 and CXCR4\/CCR5 and inhibits infection by primary virus clades A to G and group O.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Conclusion<\/jats:title>\n                        <jats:p>These results suggest the possibility of producing an anti-HIV-1 microbicide from inexpensive, widely available sources, whose safety has been established throughout centuries, provided that its quality is adequately standardized and monitored.<\/jats:p>\n                     <\/jats:sec>","DOI":"10.1186\/1471-2334-4-41","type":"journal-article","created":{"date-parts":[[2004,10,22]],"date-time":"2004-10-22T06:23:53Z","timestamp":1098426233000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":56,"title":["Punica granatum(Pomegranate) juice provides an HIV-1 entry inhibitor and candidate topical microbicide"],"prefix":"10.1186","volume":"4","author":[{"given":"A Robert","family":"Neurath","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathan","family":"Strick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun-Yao","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asim K","family":"Debnath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2004,10,14]]},"reference":[{"key":"126_CR1","volume-title":"AIDS Epidemic Update (December 2003)","author":"UNAIDS","year":"2004","unstructured":"UNAIDS: AIDS Epidemic Update (December 2003). 2004, [http:\/\/www.unaids.org\/html\/pub\/publications\/irc-pub06\/jc943-epiupdate2003_en_pdf.htm]"},{"key":"126_CR2","unstructured":"WHO\/SEARO CDS HIV\/AIDS: End-2000 global estimates (Children and adults). 2001, [http:\/\/w3.whosea.org\/hivaids\/fact.htm#End-2000%20global%20estimates]"},{"key":"126_CR3","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/nrmicro729","volume":"1","author":"RJ Shattock","year":"2003","unstructured":"Shattock RJ, Moore JP: Inhibiting sexual transmission of HIV-1 infection. Nat Rev Microbiol. 2003, 1: 25-34. 10.1038\/nrmicro729.","journal-title":"Nat Rev Microbiol"},{"key":"126_CR4","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1086\/386333","volume":"189","author":"CD Pilcher","year":"2004","unstructured":"Pilcher CD, Tien H, Eron JJ, Vernazza PL, Leu S-Y, Stewart PW, Goh L-E, Cohen MS: Brief but efficient: Acute HIV infection and the sexual transmission of HIV. J Infect Dis. 2004, 189: 1785-1792. 10.1086\/386333.","journal-title":"J Infect Dis"},{"key":"126_CR5","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1038\/nrd959","volume":"1","author":"A Stone","year":"2002","unstructured":"Stone A: Microbicides: A new approach to preventing HIV and other sexually transmitted infections. Nat Rev Drug Discov. 2002, 1: 977-985. 10.1038\/nrd959.","journal-title":"Nat Rev Drug Discov"},{"key":"126_CR6","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1016\/S0140-6736(04)15876-5","volume":"363","author":"R Shattock","year":"2004","unstructured":"Shattock R, Solomon S: Microbicides - aids to safer sex. Lancet. 2004, 363: 1002-1003. 10.1016\/S0140-6736(04)15876-5.","journal-title":"Lancet"},{"key":"126_CR7","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1016\/S0140-6736(04)15881-9","volume":"363","author":"H Brown","year":"2004","unstructured":"Brown H: Marvellous microbicides. Intravaginal gels could save millions of lives, but first someone has to prove that they work.. Lancet. 2004, 363: 1042-1043. 10.1016\/S0140-6736(04)15881-9.","journal-title":"Lancet"},{"key":"126_CR8","doi-asserted-by":"publisher","first-page":"10598","DOI":"10.1073\/pnas.1932511100","volume":"100","author":"JP Moore","year":"2003","unstructured":"Moore JP, Doms RW: The entry of entry inhibitors: a fusion of science and medicine. Proc Natl Acad Sci U S A. 2003, 100: 10598-10602. 10.1073\/pnas.1932511100.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"126_CR9","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/S0165-2478(02)00235-3","volume":"85","author":"TC Pierson","year":"2003","unstructured":"Pierson TC, Doms RW: HIV-1 entry inhibitors: new targets, novel therapies. Immunol Lett. 2003, 85: 113-118. 10.1016\/S0165-2478(02)00235-3.","journal-title":"Immunol Lett"},{"key":"126_CR10","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1084\/jem.20040426","volume":"199","author":"CW Davis","year":"2004","unstructured":"Davis CW, Doms RW: HIV Transmission: Closing all the Doors. J Exp Med. 2004, 199: 1037-1040. 10.1084\/jem.20040426.","journal-title":"J Exp Med"},{"key":"126_CR11","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1084\/jem.20022212","volume":"199","author":"Q Hu","year":"2004","unstructured":"Hu Q, Frank I, Williams V, Santos JJ, Watts P, Griffin GE, Moore JP, Pope M, Shattock RJ: Blockade of attachment and fusion receptors inhibits HIV-1 infection of human cervical tissue. J Exp Med. 2004, 199: 1065-1075. 10.1084\/jem.20022212.","journal-title":"J Exp Med"},{"key":"126_CR12","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1086\/322047","volume":"184","author":"RN Fichorova","year":"2001","unstructured":"Fichorova RN, Tucker LD, Anderson DJ: The molecular basis of nonoxynol-9-induced vaginal inflammation and its possible relevance to human immunodeficiency virus type 1 transmission. J Infect Dis. 2001, 184: 418-428. 10.1086\/322047.","journal-title":"J Infect Dis"},{"key":"126_CR13","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1095\/biolreprod.104.029603","volume":"71","author":"RN Fichorova","year":"2004","unstructured":"Fichorova RN, Bajpai M, Chandra N, Hsiu JG, Spangler M, Ratnam V, Doncel GF: Interleukin (IL)-1, IL-6 and IL-8 predict mucosal toxicity of vaginal microbicidal contraceptives. Biol Reprod. 2004, 71: 761-769. 10.1095\/biolreprod.104.029603.","journal-title":"Biol Reprod"},{"key":"126_CR14","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.1016\/S0140-6736(00)05228-4","volume":"357","author":"R Weiss","year":"2001","unstructured":"Weiss R: AIDS: unbeatable 20 years on. Lancet. 2001, 357: 2073-2074. 10.1016\/S0140-6736(00)05228-4.","journal-title":"Lancet"},{"key":"126_CR15","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1006\/biol.1998.0169","volume":"27","author":"AR Neurath","year":"1999","unstructured":"Neurath AR, Strick N, Li Y-Y, Lin K, Jiang S: Design of a \"microbicide\" for prevention of sexually transmitted diseases using \"inactive\" pharmaceutical excipients. Biologicals. 1999, 27: 11-21. 10.1006\/biol.1998.0169.","journal-title":"Biologicals"},{"key":"126_CR16","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/1471-2334-1-17","volume":"1","author":"AR Neurath","year":"2001","unstructured":"Neurath AR, Strick N, Li Y-Y, Debnath AK: Cellulose acetate phthalate, a common pharmaceutical excipient, inactivates HIV-1 and blocks the coreceptor binding site on the virus envelope glycoprotein gp120. BMC Infect Dis. 2001, 1: 17-10.1186\/1471-2334-1-17.","journal-title":"BMC Infect Dis"},{"key":"126_CR17","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1471-2334-2-6","volume":"2","author":"AR Neurath","year":"2002","unstructured":"Neurath AR, Strick N, Jiang S, Li YY, Debnath AK: Anti-HIV-1 activity of cellulose acetate phthalate: Synergy with soluble CD4 and induction of \"dead-end\" gp41 six-helix bundles. BMC Infect Dis. 2002, 2: 6-10.1186\/1471-2334-2-6.","journal-title":"BMC Infect Dis"},{"key":"126_CR18","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/1471-2334-2-27","volume":"2","author":"AR Neurath","year":"2002","unstructured":"Neurath AR, Strick N, Li Y-Y: Anti-HIV-1 activity of anionic polymers: A comparative study of candidate microbicides. BMC Infect Dis. 2002, 2: 27-10.1186\/1471-2334-2-27.","journal-title":"BMC Infect Dis"},{"key":"126_CR19","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/1471-2334-3-27","volume":"3","author":"AR Neurath","year":"2003","unstructured":"Neurath AR, Strick N, Li Y-Y: Water dispersible microbicidal cellulose acetate phthalate film. BMC Infect Dis. 2003, 3: 27-10.1186\/1471-2334-3-27.","journal-title":"BMC Infect Dis"},{"key":"126_CR20","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.virol.2004.06.022","volume":"326","author":"Q Zhao","year":"2004","unstructured":"Zhao Q, Alespeiti G, Debnath AK: A novel assay to identify entry inhibitors that block binding of HIV-1 gp120 to CCR5. Virol. 2004, 326: 299-309. 10.1016\/j.virol.2004.06.022.","journal-title":"Virol"},{"key":"126_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0042-6822(92)90729-9","volume":"188","author":"AR Neurath","year":"1992","unstructured":"Neurath AR, Strick N, Jiang S: Synthetic peptides and anti-peptide antibodies as probes to study interdomain interactions involved in virus assembly: The envelope of the human immunodeficiency virus (HIV-1). Virol. 1992, 188: 1-13. 10.1016\/0042-6822(92)90729-9.","journal-title":"Virol"},{"key":"126_CR22","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1128\/AAC.48.1.337-339.2004","volume":"48","author":"Y Van Herrewege","year":"2004","unstructured":"Van Herrewege Y, Michiels J, Van Roey J, Fransen K, Kestens L, Balzarini J, Lewi P, Vanham G, Janssen P: In vitro evaluation of nonnucleoside reverse transcriptase inhibitors UC-781 and TMC120-R147681 as human immunodeficiency virus microbicides. Antimicrob Agents Chemother. 2004, 48: 337-339. 10.1128\/AAC.48.1.337-339.2004.","journal-title":"Antimicrob Agents Chemother"},{"key":"126_CR23","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1128\/JVI.77.2.989-998.2003","volume":"77","author":"M Hsu","year":"2003","unstructured":"Hsu M, Harouse JM, Gettie A, Buckner C, Blanchard J, Cheng-Mayer C: Increased mucosal transmission but not enhanced pathogenicity of the CCR5-tropic, simian AIDS-inducing simian\/human immunodeficiency virus SHIVSF162P3 maps to envelope gp120. J Virol. 2003, 77: 989-998. 10.1128\/JVI.77.2.989-998.2003.","journal-title":"J Virol"},{"key":"126_CR24","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1086\/514109","volume":"176","author":"DH Schwartz","year":"1997","unstructured":"Schwartz DH, Castillo RC, Arango-Jaramillo S, Sharma UK, Song HF, Sridharan G: Chemokine-independent in vitro resistance to human immunodeficiency virus (HIV-1) correlating with low viremia in long-term and recently infected HIV-1-positive persons. J Infect Dis. 1997, 176: 1168-1174.","journal-title":"J Infect Dis"},{"key":"126_CR25","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1084\/jem.185.9.1681","volume":"185","author":"L Wu","year":"1997","unstructured":"Wu L, Paxton WA, Kassam N, Ruffing N, Rottman JB, Sullivan N, Choe H, Sodroski J, Newman W, Koup RA, Mackay CR: CCR5 levels and expression pattern correlate with infectability by macrophage-tropic HIV-1, in vitro. J Exp Med. 1997, 185: 1681-1691. 10.1084\/jem.185.9.1681.","journal-title":"J Exp Med"},{"key":"126_CR26","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1006\/viro.1999.0111","volume":"267","author":"H Blaak","year":"2000","unstructured":"Blaak H, Ran LJ, Rientsma R, Schuitemaker H: Susceptibility of in vitro stimulated PBMC to infection with NSI HIV-1 is associated with levels of CCR5 expression and beta-chemokine production. Virol. 2000, 267: 237-246. 10.1006\/viro.1999.0111.","journal-title":"Virol"},{"key":"126_CR27","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/978-1-349-11888-5_3","volume-title":"Techniques in HIV Research","author":"S Gartner","year":"1990","unstructured":"Gartner S, Popovic M: Virus isolation and production. Techniques in HIV Research. Edited by: Aldovini A and Walker BD. 1990, New York, M. Stockton Press, 53-70."},{"key":"126_CR28","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/nm0502-425","volume":"8","author":"RJ Shattock","year":"2002","unstructured":"Shattock RJ, Doms RW: AIDS models: Microbicides could learn from vaccines. Nat Med. 2002, 8: 425-10.1038\/nm0502-425.","journal-title":"Nat Med"},{"key":"126_CR29","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1089\/aid.1988.4.187","volume":"4","author":"MA Skinner","year":"1988","unstructured":"Skinner MA, Ting R, Langlois AJ, Weinhold KJ, Lyerly HK, Javaherian K, Matthews TJ: Characteristics of a neutralizing monoclonal antibody to the HIV envelope glycoprotein. AIDS Res Hum Retroviruses. 1988, 4: 187-197.","journal-title":"AIDS Res Hum Retroviruses"},{"key":"126_CR30","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1159\/000421950","volume-title":"Immunochemistry of AIDS, Chemical Immunology, Vol. 56","author":"S Laal","year":"1993","unstructured":"Laal S, Zolla-Pazner S: Epitopes of HIV-1 glycoproteins recognized by the human immune system. Immunochemistry of AIDS, Chemical Immunology, Vol. 56. Edited by: NorrbyE. 1993, Basel, Karger, 91-111."},{"key":"126_CR31","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1038\/31405","volume":"393","author":"PD Kwong","year":"1998","unstructured":"Kwong PD, Wyatt R, Robinson J, Sweet RW, Sodroski J, Hendrickson WA: Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody. Nature. 1998, 393: 648-659. 10.1038\/31405.","journal-title":"Nature"},{"key":"126_CR32","doi-asserted-by":"publisher","first-page":"9888","DOI":"10.1128\/JVI.76.19.9888-9899.2002","volume":"76","author":"SH Xiang","year":"2002","unstructured":"Xiang SH, Kwong PD, Gupta R, Rizzuto CD, Casper DJ, Wyatt R, Wang L, Hendrickson WA, Doyle ML, Sodroski J: Mutagenic stabilization and\/or disruption of a CD4-bound state reveals distinct conformations of the human immunodeficiency virus type 1 gp120 envelope glycoprotein. J Virol. 2002, 76: 9888-9899. 10.1128\/JVI.76.19.9888-9899.2002.","journal-title":"J Virol"},{"key":"126_CR33","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1128\/JVI.77.1.642-658.2003","volume":"77","author":"R Pantophlet","year":"2003","unstructured":"Pantophlet R, Ollmann Saphire E, Poignard P, Parren PWI, Wilson IA, Burton DR: Fine mapping of the interaction of neutralizing and nonneutralizing monoclonal antibodies with the CD4 binding site of human immunodeficiency virus type 1 gp120. J Virol. 2003, 77: 642-658. 10.1128\/JVI.77.1.642-658.2003.","journal-title":"J Virol"},{"key":"126_CR34","doi-asserted-by":"publisher","first-page":"3097","DOI":"10.1073\/pnas.88.8.3097","volume":"88","author":"P Westervelt","year":"1991","unstructured":"Westervelt P, Gendelman HE, Ratner L: Identification of a determinant within the human immunodeficiency virus 1 surface envelope glycoprotein critical for productive infection of primary monocytes. Proc Natl Acad Sci U S A. 1991, 88: 3097-3101.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"126_CR35","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1128\/jvi.66.4.2577-2582.1992","volume":"66","author":"P Westervelt","year":"1992","unstructured":"Westervelt P, Trowbridge DB, Epstein LG, Blumberg BM, Li Y, Hahn BH, Shaw GM, Price RW, Ratner L: Macrophage tropism determinants of human immunodeficiency virus type 1 in vivo. J Virol. 1992, 66: 2577-2582.","journal-title":"J Virol"},{"key":"126_CR36","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1126\/science.280.5371.1949","volume":"280","author":"CD Rizzuto","year":"1998","unstructured":"Rizzuto CD, Wyatt R, Hernandez-Ramos N, Sun Y, Kwong PD, Hendrickson WA, Sodroski J: A conserved HIV gp120 glycoprotein structure involved in chemokine receptor binding. Science. 1998, 280: 1949-1953. 10.1126\/science.280.5371.1949.","journal-title":"Science"},{"key":"126_CR37","doi-asserted-by":"publisher","first-page":"8953","DOI":"10.1128\/JVI.76.17.8953-8957.2002","volume":"76","author":"EG Cormier","year":"2002","unstructured":"Cormier EG, Dragic T: The crown and stem of the V3 loop play distinct roles in human immunodeficiency virus type 1 envelope glycoprotein interactions with the CCR5 coreceptor. J Virol. 2002, 76: 8953-8957. 10.1128\/JVI.76.17.8953-8957.2002.","journal-title":"J Virol"},{"key":"126_CR38","doi-asserted-by":"publisher","first-page":"3832","DOI":"10.1128\/JVI.77.6.3832-3837.2003","volume":"77","author":"P Suphaphiphat","year":"2003","unstructured":"Suphaphiphat P, Thitithanyanont A, Paca-Uccaralertkun S, Essex M, Lee T-H: Effect of amino acid substitution of the V3 and bridging sheet residues in human immunodeficiency virus type 1 subtype C gp120 on CCR5 utilization. J Virol. 2003, 77: 3832-3837. 10.1128\/JVI.77.6.3832-3837.2003.","journal-title":"J Virol"},{"key":"126_CR39","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s00894-003-0154-9","volume":"9","author":"S Liu","year":"2003","unstructured":"Liu S, Fan S, Sun Z: Structural and functional characterization of the human CCR5 receptor in complex with HIV gp120 envelope glycoprotein and CD4 receptor by molecular modeling studies. J Mol Model. 2003, 9: 329-336. 10.1007\/s00894-003-0154-9.","journal-title":"J Mol Model"},{"key":"126_CR40","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1136\/bmj.321.7269.1153","volume":"321","author":"P Langley","year":"2000","unstructured":"Langley P: Why a pomegranate?. BMJ. 2000, 321: 1153-1154. 10.1136\/bmj.321.7269.1153.","journal-title":"BMJ"},{"key":"126_CR41","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1038\/ni0904-867","volume":"5","author":"WC Greene","year":"2004","unstructured":"Greene WC: The brightening future of HIV therapeutics. Nat Immunol. 2004, 5: 867-871. 10.1038\/ni0904-867.","journal-title":"Nat Immunol"},{"key":"126_CR42","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/S0889-1575(02)91071-9","volume":"15","author":"E Poyrazoglu","year":"2002","unstructured":"Poyrazoglu E, Goekmen V, Artik N: Organic acids and phenolic compounds in pomegranates (Punica granatum L.) Grown in Turkey. J Food Composition and Analysis. 2002, 15: 567-575. 10.1016\/S0889-1575(02)91071-9.","journal-title":"J Food Composition and Analysis"},{"key":"126_CR43","unstructured":"Module 2: Phytochemicals (minerals, phytamins, and vitamins). 2003, [http:\/\/www.ars-grin.gov\/duke\/syllabus\/module2.htm]"},{"key":"126_CR44","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1177\/095632029300400406","volume":"4","author":"N Mahmood","year":"1993","unstructured":"Mahmood N, Moore PS, De Tommasi N, De Simone F, Colman S, Hay AJ, Pizza C: Inhibition of HIV infection by caffeoylquinic acid derivatives. Antiviral Chem Chemother. 1993, 4: 235-240.","journal-title":"Antiviral Chem Chemother"},{"key":"126_CR45","doi-asserted-by":"publisher","first-page":"S138","DOI":"10.1002\/(SICI)1099-1573(1998)12:1+<S138::AID-PTR276>3.0.CO;2-5","volume":"12","author":"C Ma","year":"1998","unstructured":"Ma C, Nakamura N, Miyashiro H, Hattori M, Shimotohno K: Inhibitory effects of ursolic acid derivatives from cynomorium songaricum, and related triterpenes on human immunodeficiency viral protease. Phytotherapy Research. 1998, 12 : S138-S142. 10.1002\/(SICI)1099-1573(1998)12:1+<S138::AID-PTR276>3.0.CO;2-5.","journal-title":"Phytotherapy Research"},{"key":"126_CR46","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1006\/bbrc.1996.1759","volume":"229","author":"N Mahmood","year":"1996","unstructured":"Mahmood N, Piacente S, Pizza C, Burke A, Khan AI, Hay AJ: The anti-HIV activity and mechanisms of action of pure compounds isolated from Rosa damascena. Biochem Biophys Res Commun. 1996, 229: 73-79. 10.1006\/bbrc.1996.1759.","journal-title":"Biochem Biophys Res Commun"},{"key":"126_CR47","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1076\/phbi.36.1.29.4626","volume":"36","author":"N DeTommasi","year":"1998","unstructured":"DeTommasi N, Piacente S, Rastrelli L, Mahmood N, Pizza C: Anti-HIV activity directed fractionation of the extracts of Margyricarpus setosus. Pharmaceutical Biology. 1998, 36: 29-32. 10.1076\/phbi.36.1.29.4626.","journal-title":"Pharmaceutical Biology"},{"key":"126_CR48","unstructured":"Pomegranates could help in battle against AIDS. Reuters NewMedia, Inc. March 10 1996, [http:\/\/www.aegis.com\/news\/re\/1996\/RE960310.html]"},{"key":"126_CR49","unstructured":"Medical breakthrough. British Muslims Monthly Survey. 1996, IV (3): 6-[http:\/\/artsweb.bham.ac.uk\/bmms\/1996\/03March96.html#Medical%20breakthrough]"},{"key":"126_CR50","unstructured":"Jassim SAA, Denyer SP, Stewart GSAB: Antiviral or antifungal composition comprising an extract of pomegranate rind or other plants and method of use. US Patent . 5,840,308-November 24 1998"},{"key":"126_CR51","unstructured":"Shehadeh AA: Herbal extract composition and method with immune-boosting capability. US Patent . 6,030,622-Febuary 29 2000"},{"key":"126_CR52","unstructured":"Jassim SAA, Denyer SP, Stewart GSAB: Antiviral or antifungal composition and method. US Patent . 6,187,316-February 2 2001"},{"key":"126_CR53","unstructured":"Jassim SAA, Denyer SP: Antiviral or antifungal compositon and method. US Patent Application . 20020064567-May 30 2002"},{"key":"126_CR54","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1002\/prot.20061","volume":"55","author":"S-T Hsu","year":"2004","unstructured":"Hsu S-T, Bonvin AMJJ: Atomic insight into the CD4 binding-induced conformational changes in HIV-1 gp120. Proteins. 2004, 55: 582-593. 10.1002\/prot.20061.","journal-title":"Proteins"},{"key":"126_CR55","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1177\/095632029400500506","volume":"5","author":"AR Neurath","year":"1994","unstructured":"Neurath AR, Strick N, Lin K, Debnath AK, Jiang S: Tin protoporphyrin IX used in control of heme metabolism in humans effectively inhibits HIV-1 infection. Antiviral Chem Chemother. 1994, 5: 322-330.","journal-title":"Antiviral Chem Chemother"},{"key":"126_CR56","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1089\/aid.1995.11.87","volume":"11","author":"L Hammar","year":"1995","unstructured":"Hammar L, Hirsch I, Machado AA, de Mareuil J, Baillon JG, Bolmont C, Chermann J-C: Lectin-mediated effects of HIV type 1 infection in vitro. AIDS Res Hum Retroviruses. 1995, 11: 87-95.","journal-title":"AIDS Res Hum Retroviruses"},{"key":"126_CR57","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/nm833","volume":"9","author":"RS Veazey","year":"2003","unstructured":"Veazey RS, Shattock RJ, Pope M, Kirijan JC, Jones J, Hu Q, Ketas T, Marx PA, Klasse PJ, Burton DR, Moore JP: Prevention of virus transmission to macaque monkeys by a vaginally applied monoclonal antibody to HIV-1 gp120. Nat Med. 2003, 9: 343-346. 10.1038\/nm833.","journal-title":"Nat Med"},{"key":"126_CR58","first-page":"14","volume":"Sept.","author":"S Garg","year":"2001","unstructured":"Garg S, Tambweker KR, Vermani K, Garg A, Kaul CL, Zaneveld LJD: Compendium of pharmaceutical excipients for vaginal formulations. Pharmaceutical Technology Drug Delivery. 2001, Sept.: 14-24.","journal-title":"Pharmaceutical Technology Drug Delivery"},{"key":"126_CR59","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1002\/1521-379X(200206)54:6<260::AID-STAR260>3.0.CO;2-Z","volume":"54","author":"WR Yao","year":"2002","unstructured":"Yao WR, Yao HY: Adsorbent characteristics of porous starch. Starch\/Starke. 2002, 54: 260-263. 10.1002\/1521-379X(200206)54:6<260::AID-STAR260>3.0.CO;2-Z.","journal-title":"Starch\/Starke"},{"key":"126_CR60","unstructured":"Whistler RL: Microporous granular starch matrix compositions. US Patent . 4,985,082-January 15 1991"},{"key":"126_CR61","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1111\/j.1365-2621.1995.tb06247.x","volume":"60","author":"C Berset","year":"1995","unstructured":"Berset C, Clermont H, Cheval S: Natural red colorant effectiveness as influenced by absorptive supports. J Food Sci. 1995, 60: 858-861, 879.","journal-title":"J Food Sci"},{"key":"126_CR62","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/star.19740260103","volume":"26","author":"R Stute","year":"1974","unstructured":"Stute R, Woelk HU: Interaction between starch and reactive dyes. New technique for the investigation of starch. II. Influence on fixation reaction of starch. Starch\/Starke. 1974, 26: 1-9.","journal-title":"Starch\/Starke"},{"key":"126_CR63","first-page":"518","volume":"63","author":"M Seguchi","year":"1986","unstructured":"Seguchi M: Dye binding to the surface of wheat starch granules. Cereal Chemistry. 1986, 63: 518-520.","journal-title":"Cereal Chemistry"},{"key":"126_CR64","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1002\/star.19950470506","volume":"47","author":"P Tomasik","year":"1995","unstructured":"Tomasik P, Wang Y-J, Jane JL: Complexes of starch with low-molecular saccharides. Starch\/Starke. 1995, 47: 185-191.","journal-title":"Starch\/Starke"},{"key":"126_CR65","doi-asserted-by":"publisher","first-page":"2801","DOI":"10.1021\/jf030035t","volume":"51","author":"G Zhang","year":"2003","unstructured":"Zhang G, Maladen MD, Hamaker BR: Detection of a novel three component complex consisting of starch, protein, and free fatty acids. J Agric Food Chem. 2003, 51: 2801-2805. 10.1021\/jf030035t.","journal-title":"J Agric Food Chem"},{"key":"126_CR66","first-page":"236","volume":"67","author":"JM Johnson","year":"1990","unstructured":"Johnson JM, Davis EA, Gordon J: Lipid binding of modified corn starches studies by electron spin resonance. Cereal Chemistry. 1990, 67: 236-240.","journal-title":"Cereal Chemistry"},{"key":"126_CR67","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1081\/IAS-120030521","volume":"25","author":"VJ Tomazic-Jezic","year":"2004","unstructured":"Tomazic-Jezic VJ, Lucas AD, Sanchez BA: Binding and measuring natural rubber latex proteins on glove powder. J Immunoassay Immunochem. 2004, 25: 109-123.","journal-title":"J Immunoassay Immunochem"},{"key":"126_CR68","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1002\/(SICI)1521-379X(199805)50:5<184::AID-STAR184>3.0.CO;2-7","volume":"50","author":"B Conde-Petit","year":"1998","unstructured":"Conde-Petit B, Nuessli J, Handschin S, Escher F: Comparative charaterization of aqueous starch dispersions by light microscopy, rheometry, and iodine binding behavior. Starch\/Starke. 1998, 50: 184-192. 10.1002\/(SICI)1521-379X(199805)50:5<184::AID-STAR184>3.3.CO;2-Z.","journal-title":"Starch\/Starke"},{"key":"126_CR69","volume-title":"Microbicides","author":"J Moore","year":"2004","unstructured":"Moore J, Wainberg M, Amman A, Veazey R, Pope M, Shattock RJ, Doms RW: Development of fusion\/entry inhibitors as topical microbicides. Microbicides. 2004, March 28-31 2004, London, [http:\/\/www.microbicides2004.org.uk\/presentations\/johnmoore.ppt]"},{"key":"126_CR70","doi-asserted-by":"crossref","unstructured":"Neurath AR, Strick N: Biodegradable microbicidal vaginal barrier device. US Patent . 6,572,875-June 3 2003","DOI":"10.1186\/1471-2334-3-27"},{"key":"126_CR71","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1107\/S0021889891004399","volume":"24","author":"PJ Kraulis","year":"1991","unstructured":"Kraulis PJ: MOLSCRIPT: a program to produce both detailed and schematic plots of protein structures. J Appl Cryst. 1991, 24: 946-950. 10.1107\/S0021889891004399.","journal-title":"J Appl Cryst"},{"key":"126_CR72","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/S0263-7855(98)80030-1","volume":"6","author":"DJ Bacon","year":"1988","unstructured":"Bacon DJ, Anderson WF: A fast algorithm for rendering space-filling molecule pictures. J Mol Graphics. 1988, 6: 219-220. 10.1016\/S0263-7855(98)80030-1.","journal-title":"J Mol Graphics"},{"key":"126_CR73","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/S0076-6879(97)77028-9","volume":"277","author":"EA Merritt","year":"1997","unstructured":"Merritt EA, Bacon DJ: Raster3D: Photorealistic molecular graphics. Methods Enzymol. 1997, 277: 505-524.","journal-title":"Methods Enzymol"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-4-41.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2334-4-41\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-4-41","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-4-41.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,7]],"date-time":"2024-10-07T12:43:16Z","timestamp":1728304996000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/1471-2334-4-41"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,10,14]]},"references-count":73,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2004,12]]}},"alternative-id":["126"],"URL":"https:\/\/doi.org\/10.1186\/1471-2334-4-41","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,10,14]]},"assertion":[{"value":"8 July 2004","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2004","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2004","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"41"}}